Director of Research at Purdue University
Refeyn is pleased to announce that Paul C. Collins has joined its Scientific Advisory Board (SAB). Paul brings a wealth of experience spanning synthetic small molecules, monoclonal antibodies, therapeutic proteins and other large molecules, as well as peptides and other genetic medicine-related treatment modalities. He worked for over 30 years for Merck and Eli Lilly, primarily in R&D roles related to new molecule process development.
Bringing together trusted advisors from academia and industry, Refeyn’s SAB helps guide the development of mass photometry applications across biopharma discovery, development, and manufacturing.
To learn more about Refeyn’s SAB, visit: About Us – Refeyn
